Inflammatory Bowel Disease in Children and Adolescents
- 1 November 2015
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 169 (11), 1053-1060
- https://doi.org/10.1001/jamapediatrics.2015.1982
Abstract
The inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn disease, are chronic inflammatory disorders of the gastrointestinal tract most often diagnosed in adolescence and young adulthood, with a rising incidence in pediatric populations. These disorders are common enough in children that most pediatricians and other pediatric clinicians will encounter children with IBD in their general practice. Inflammatory bowel disease is caused by a dysregulated mucosal immune response to the intestinal microflora in genetically predisposed hosts. Although children can present with the classic symptoms of weight loss, abdominal pain, and bloody diarrhea, many present with nonclassic symptoms of isolated poor growth, anemia, or other extraintestinal manifestations. Once IBD is diagnosed, the goals of therapy consist of eliminating symptoms, normalizing quality of life, restoring growth, and preventing complications while minimizing the adverse effects of medications. Unique considerations when treating children and adolescents with IBD include attention to the effects of the disease on growth and development, bone health, and psychosocial functioning. The purpose of this review is to provide a contemporary overview of the epidemiologic features, pathogenesis, diagnosis, and management of IBD in children and adolescents.Keywords
This publication has 73 references indexed in Scilit:
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US PopulationDigestive Diseases and Sciences, 2012
- Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease 12Inflammatory Bowel Diseases, 2011
- Genetics and pathogenesis of inflammatory bowel diseaseNature, 2011
- Aminosalicylates for induction of remission or response in Crohn's diseasePublished by Wiley ,2010
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseNew England Journal of Medicine, 2010
- Endoscopic ultrasound to guide the combined medical and surgical management of pediatric perianal Crohnʼs diseaseInflammatory Bowel Diseases, 2010
- A Meta-analytic Review of the Psychosocial Adjustment of Youth with Inflammatory Bowel DiseaseJournal of Pediatric Psychology, 2010
- Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 ReceptorNew England Journal of Medicine, 2009
- Safety, Efficacy, and Pharmacokinetics of Balsalazide in Pediatric Patients With Mild‐to‐Moderate Active Ulcerative Colitis: Results of a Randomized, Double‐blind StudyJournal of Pediatric Gastroenterology and Nutrition, 2009